Anti-Inflammatory Effects of Dipeptidyl Peptidase-1 Inhibition: A Posthoc Analysis Of The WILLOW Trial

Project Details

StatusActive
Effective start/end date1/12/23 → 31/05/26

Funding

  • Insmed, Inc. (WILLOW): £179,346.00